Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

01.09.2015 | short review | Ausgabe 3/2015

memo - Magazine of European Medical Oncology 3/2015

ASH 2014 update: Myelodysplastic syndromes and acute myeloid leukemia

Zeitschrift:
memo - Magazine of European Medical Oncology > Ausgabe 3/2015
Autor:
MBA Univ.-Prof. Dr. Michael Pfeilstöcker

Abstract

Treatment of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), especially in older patients with comorbidities, is still a challenge and awaits further improvement regarding outcomes. Therefore data presented on this topic at the 2014 American Society of Hematology (ASH) meeting are of importance and need to be discussed in the context of current and future clinical practice. This review covers studies for AML and MDS (excluding transplantation) reported at the last ASH meeting that demonstrate progress in this field and suggest a way forward from chemotherapy to biological treatment approaches.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 3/2015

memo - Magazine of European Medical Oncology 3/2015 Zur Ausgabe